Donato Amodio: Did Amodio et al. show cases of recurrent myocarditis following mRNA technology COVID gene vaccine despite a prior episode with full clinical recovery? Yes! patients presented with
by Paul Alexander
patients presented with fever and chest pain few days after their second dose of Pfizer BNT162b2 mRNA Covid-19 Vaccine; 'The blood exams showed increased cardiac enzymes.'
‘describe two cases experiencing recurrent myocarditis following mRNA COVID-19 vaccine despite a prior episode with full clinical recovery. Between September 2021-September 2022 we observed two male adolescents with recurrent myocarditis related to mRNA-based-COVID19 vaccine. During the first episode both patients presented with fever and chest pain few days after their second dose of BNT162b2 mRNA Covid-19 Vaccine (Comirnaty®). The blood exams showed increased cardiac enzymes. In addition, complete viral panel was run, showing HHV7 positivity in a single case. The left ventricular ejection fraction (LVEF) was normal at echocardiogram but cardiac magnetic resonance scanning (CMR) was consistent with myocarditis.’